All Stories

  1. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease

    Article • Current Protein and Peptide Science, October 2017, Bentham Science Publishers

    Bengt Lindholm, Prof Peter Stenvinkel

  2. Biomarkers are weak predictors of outcome in CKD5 patients

    Article • Clinical Journal of the American Society of Nephrology, June 2016, American Society of Nephrology

    Prof Peter Stenvinkel, Bengt Lindholm

  3. Climate change and kidney disease

    Article • Clinical Journal of the American Society of Nephrology, May 2016, American Society of Nephrology

    Ricardo Correa-Rotter, Prof Vivekanand Jha, Ramon García-Trabanino, Prof Peter Stenvinkel, LAURA G SANCHEZ-LOZADA

  4. The obese patient (metabolic syndrome)

    Article • October 2015, Oxford University Press (OUP)

    Prof Peter Stenvinkel

  5. Vascular Effects of Inflammation and Oxidative Stress in CKD

    Article • September 2014, Springer Science + Business Media

    Prof Peter Stenvinkel

  6. Naohito

    Article • Clinical Journal of the American Society of Nephrology, July 2014, American Society of Nephrology

    Naohito Isoyama, Prof Peter Stenvinkel, Bengt Lindholm

  7. The Relationship between IL-10 Levels and Cardiovascular Events in Patients with CKD

    Article • Clinical Journal of the American Society of Nephrology, May 2014, American Society of Nephrology

    Professor Cengizhan ACIKEL, dr yalcin solak, Professor Mahmut I Yilmaz, Prof Peter Stenvinkel

  8. Clinical Correlates of Insulin Sensitivity and Its Association with Mortality among Men with CKD Stages 3 and 4

    Article • Clinical Journal of the American Society of Nephrology, January 2014, American Society of Nephrology

    Dr Hong Xu, Prof Peter Stenvinkel, Bengt Lindholm, Dr Johan Ärnlöv

  9. Effects of dopamine on leptin release and leptin gene (OB) expression in adipocytes from obese and hypertensive patients

    Article • International Journal of Nephrology and Renovascular Disease, November 2013, Taylor & Francis

    Dr Oliva Mejia Rodríguez, Prof Peter Stenvinkel, Bengt Lindholm

  10. IGF-1 and Survival in ESRD

    Article • Clinical Journal of the American Society of Nephrology, October 2013, American Society of Nephrology

    Prof Peter Stenvinkel, Bengt Lindholm

  11. Changes in Body Weight and Subsequent Mortality: Are We Any Closer to Knowing How to Deal with Obesity in ESRD?

    Article • Clinical Journal of the American Society of Nephrology, September 2013, American Society of Nephrology

    Prof Peter Stenvinkel, Professor Kamyar Kalantar-Zadeh

  12. Inflammation in Chronic Kidney Disease

    Article • January 2013, Elsevier

    Prof Peter Stenvinkel

  13. Uremic Toxicity

    Article • January 2013, Elsevier

    Prof Peter Stenvinkel

  14. Effects of Hemodiafiltration on Uremic Inflammation

    Article • Blood Purification, January 2013, Karger Publishers

    Prof Peter Stenvinkel

  15. Can Treating Persistent Inflammation Limit Protein Energy Wasting?

    Article • Seminars in Dialysis, October 2012, Wiley

    Prof Peter Stenvinkel

  16. Cytokines

    Article • September 2012, Wiley

    Prof Peter Stenvinkel

  17. Serum Albumin as Predictor of Nutritional Status in Patients with ESRD

    Article • Clinical Journal of the American Society of Nephrology, June 2012, American Society of Nephrology

    Prof Peter Stenvinkel, Bengt Lindholm

  18. Baseline Levels and Trimestral Variation of Triiodothyronine and Thyroxine and Their Association with Mortality in Maintenance Hemodialysis Patients

    Article • Clinical Journal of the American Society of Nephrology, January 2012, American Society of Nephrology

    Prof Peter Stenvinkel, Bengt Lindholm

  19. Prolactin Levels, Endothelial Dysfunction, and the Risk of Cardiovascular Events and Mortality in Patients with CKD

    Article • Clinical Journal of the American Society of Nephrology, December 2011, American Society of Nephrology

    Professor Mahmut I Yilmaz, Prof Peter Stenvinkel, MD JOHN KYRIAZIS

  20. Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased?

    Article • Nature Reviews Nephrology, December 2011, Nature

    Prof Peter Stenvinkel

  21. Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease

    Article • Clinical Journal of the American Society of Nephrology, December 2011, American Society of Nephrology

    Prof Peter Stenvinkel, Bengt Lindholm

  22. C-Reactive Protein in End-Stage Renal Disease: Are There Reasons to Measure It?

    Article • Blood Purification, February 2011, Karger Publishers

    Prof Peter Stenvinkel

  23. Inflammation as a target for improving health in chronic kidney disease

    Article • F1000 Medicine Reports, December 2010, Faculty of 1000, Ltd.

    Prof Peter Stenvinkel

  24. Cardiovascular Disease in Chronic Kidney Disease

    Article • January 2010, Elsevier

    Prof Peter Stenvinkel

  25. Nutrition: Can ghrelin improve appetite in uremic wasting?

    Article • Nature Reviews Nephrology, December 2009, Nature

    Prof Peter Stenvinkel

  26. Loop Diuretic-induced Pancreatitis with Rechallenge in a Patient with Malignant Hypertension and Renal Insufficiency

    Article • Acta Medica Scandinavica, April 2009, Wiley

    Prof Peter Stenvinkel

  27. Does the Uremic Milieu Affect the Epigenotype?

    Article • Journal of Renal Nutrition, January 2009, Elsevier

    Prof Peter Stenvinkel

  28. New insights on inflammation in chronic kidney disease–genetic and non-genetic factors

    Article • Néphrologie & Thérapeutique, July 2006, Elsevier

    Prof Peter Stenvinkel

  29. Reply

    Article • Blood Purification, February 2006, Karger Publishers

    Prof Peter Stenvinkel

  30. In Reply

    Article • American Journal of Kidney Diseases, August 2005, Elsevier

    Prof Peter Stenvinkel

  31. In reply:

    Article • American Journal of Kidney Diseases, July 2001, Elsevier

    Prof Peter Stenvinkel

  32. Malnutrition and Chronic Inflammation as Risk Factors for Cardiovascular Disease in Chronic Renal Failure

    Article • Blood Purification, December 2000, Karger Publishers

    Prof Peter Stenvinkel

  33. Inflammatory and Atherosclerotic Interactions in the Depleted Uremic Patient

    Article • Blood Purification, December 2000, Karger Publishers

    Prof Peter Stenvinkel

  34. Hormonal status in critically ill patients with or without acute renal failure

    Article • January 1998, Springer Science + Business Media

    Prof Peter Stenvinkel

  35. Plasma Lipoprotein(a) Is Related to Peritoneal Albumin Losses

    Article • Nephron, January 1997, Karger Publishers

    Prof Peter Stenvinkel

  36. Lipoprotein(a) in nephrotic syndrome

    Article • Kidney International, November 1993, Elsevier

    Prof Peter Stenvinkel

  37. Faculty of 1000 evaluation for Kidney Disease and Increased Mortality Risk in Type 2 Diabetes.

    Article • Faculty of 1000, Ltd.

    Prof Peter Stenvinkel